A prospective, single-arm, multicenter clinical study of cadonilimab combined with surufatinib in the treatment of progress advanced soft tissue sarcoma after system chemotherapy
Non targeted metabonomics study of heart failure based on UHPLC-QTOF/MS and the study on the pathogenesis of heart failure
100 Clinical Results associated with Shanghai Tongren Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shanghai Tongren Pharmaceutical Co., Ltd.
100 Deals associated with Shanghai Tongren Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shanghai Tongren Pharmaceutical Co., Ltd.